Effectiveness ofYoga Practices on Depression and Anxiety Levels in Chronic Kidney Disease Patients

Phase 4

• Conditions: Health Condition 1: N189- Chronic kidney disease, unspecified

• Registration Number: CTRI/2024/03/063444
• Lead Sponsor: J S Ayurveda Mahavidyalaya and P D Patel Ayurveda Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 April 2024

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Those between 18 and 80 years of age, who gave written informed consent, and who were

mentally and physically fit up to a minimum level to understand and perform yoga practices

were included.

CKD patients under treatment (both non-dialysis and undergoing dialysis)

CKD patients with diabetes type 2/ hypertension controlled with medications

CKD patients are advised to continue their present medications as prescribed by the doctor.

Yoga practices will be added as complimentary along with medications.

Participants were told to practice yoga regularly for at least 6 days a week for 50–60 min a day.

All Yoga practices are not mandatory, if the patient is not able to do it.

Exclusion Criteria

Those aged less than 18 years and above 80 years.

Individuals with ischemic heart disease, post-coronary artery bypass grafting, comorbid

coronary artery disease, single working kidney, congenital renal malformations, or a history of

past carcinoma are excluded from the study.

Either anxiety and depression questionnaire or any one among anxiety or depression

questionnaire should be diagnosed positive with the respective questionnaire

1. Hamilton Anxiety Rating Scale (HAM-A)-Patients scoring 0 score while using the

questionnaire should be excluded

2. PHQ-9 Patient Depression Questionnaire - If the combined score for the -very

difficult/extremely difficult- (grades 2 or 3) is fewer than 2 ticks should be excluded

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Change in depression levelTimepoint: baseline, after 21 days of intervention

Secondary Outcome Measures

Name	Time	Method
Change in anxiety levelTimepoint: baseline, after 21 days of intervention